Veradermics, Inc

Veradermics, Inc (MANE) priced its initial public offering on Feb 4, 2026 at $17.00 per share, above its $14.00–$16.00 range, raising $256.3M, and listed on NYSE. At the IPO price its market capitalization was about $596.3M. Jefferies was lead-left underwriter, joined by Leerink Partners, Citigroup and Cantor. Ropes & Gray advised the company and Cooley advised the underwriters.

Veradermics, Inc is a dermatologist-founded, late clinical-stage biopharmaceutical company developing therapeutics for aesthetic and dermatological conditions. Its initial focus is better treatments for pattern hair loss.

Status

IPO

Ticker

MANE

Exchange

NYSE

Priced

Feb 4, 2026

IPO price

$17.00

Price range

$14.00–$16.00

Raised

$256.3M

Market cap at IPO price

$596.3M

First filed

Jan 9, 2026

Underwriters

Jefferies, Leerink Partners, Citigroup and Cantor

Company counsel

Ropes & Gray

Underwriters' counsel

Cooley

Sector

Biotech & pharma

Country / state

CT

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.